1. Home
  2. ISSC vs ALLO Comparison

ISSC vs ALLO Comparison

Compare ISSC & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISSC
  • ALLO
  • Stock Information
  • Founded
  • ISSC 1988
  • ALLO 2017
  • Country
  • ISSC United States
  • ALLO United States
  • Employees
  • ISSC N/A
  • ALLO N/A
  • Industry
  • ISSC EDP Services
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ISSC Technology
  • ALLO Health Care
  • Exchange
  • ISSC Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ISSC 273.0M
  • ALLO 252.9M
  • IPO Year
  • ISSC 2000
  • ALLO 2018
  • Fundamental
  • Price
  • ISSC $12.46
  • ALLO $1.34
  • Analyst Decision
  • ISSC
  • ALLO Buy
  • Analyst Count
  • ISSC 0
  • ALLO 12
  • Target Price
  • ISSC N/A
  • ALLO $8.80
  • AVG Volume (30 Days)
  • ISSC 319.2K
  • ALLO 2.9M
  • Earning Date
  • ISSC 08-14-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • ISSC N/A
  • ALLO N/A
  • EPS Growth
  • ISSC 78.33
  • ALLO N/A
  • EPS
  • ISSC 0.66
  • ALLO N/A
  • Revenue
  • ISSC $77,434,581.00
  • ALLO N/A
  • Revenue This Year
  • ISSC $66.10
  • ALLO N/A
  • Revenue Next Year
  • ISSC $17.23
  • ALLO $100.00
  • P/E Ratio
  • ISSC $18.73
  • ALLO N/A
  • Revenue Growth
  • ISSC 72.82
  • ALLO N/A
  • 52 Week Low
  • ISSC $5.30
  • ALLO $0.86
  • 52 Week High
  • ISSC $20.00
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • ISSC 51.68
  • ALLO 62.84
  • Support Level
  • ISSC $11.95
  • ALLO $1.20
  • Resistance Level
  • ISSC $12.79
  • ALLO $1.43
  • Average True Range (ATR)
  • ISSC 0.46
  • ALLO 0.07
  • MACD
  • ISSC 0.17
  • ALLO 0.02
  • Stochastic Oscillator
  • ISSC 80.20
  • ALLO 69.83

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: